Medicover AB (publ)
MCVEF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $2,092 | $1,746 | $1,510 | $1,377 |
| % Growth | 19.8% | 15.6% | 9.6% | – |
| Cost of Goods Sold | $1,644 | $1,387 | $1,175 | $982 |
| Gross Profit | $448 | $359 | $336 | $395 |
| % Margin | 21.4% | 20.6% | 22.2% | 28.7% |
| R&D Expenses | $7 | $0 | $4 | $3 |
| G&A Expenses | $58 | $219 | $41 | $35 |
| SG&A Expenses | $94 | $297 | $64 | $55 |
| Sales & Mktg Exp. | $36 | $78 | $24 | $20 |
| Other Operating Expenses | $277 | $1 | $0 | $0 |
| Operating Expenses | $378 | $298 | $279 | $236 |
| Operating Income | $70 | $61 | $56 | $159 |
| % Margin | 3.4% | 3.5% | 3.7% | 11.6% |
| Other Income/Exp. Net | -$50 | -$38 | -$36 | -$16 |
| Pre-Tax Income | $20 | $24 | $20 | $144 |
| Tax Expense | $6 | $5 | $6 | $37 |
| Net Income | $17 | $18 | $12 | $102 |
| % Margin | 0.8% | 1% | 0.8% | 7.4% |
| EPS | 0.11 | 0.12 | 0.075 | 0.67 |
| % Growth | -8.3% | 59.4% | -88.8% | – |
| EPS Diluted | 0.11 | 0.12 | 0.075 | 0.67 |
| Weighted Avg Shares Out | 150 | 149 | 149 | 148 |
| Weighted Avg Shares Out Dil | 150 | 150 | 149 | 148 |
| Supplemental Information | – | – | – | – |
| Interest Income | $5 | $4 | $3 | $1 |
| Interest Expense | $61 | $51 | $35 | $20 |
| Depreciation & Amortization | $98 | $182 | $162 | $111 |
| EBITDA | $171 | $257 | $216 | $275 |
| % Margin | 8.2% | 14.7% | 14.3% | 20% |